جاهز للتشغيل
جاهز للتشغيل
Johnson & Johnson has reached a settlement to pay approximately $5.5 billion to resolve around 76,000 lawsuits alleging its talc products caused ovarian cancer. The deal covers most outstanding claims and requires approval from 95% of claimants before becoming final. J&J denies wrongdoing and views the settlement as a means to efficiently end years of litigation.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading